Inhale Therapeutic Systems deal

If the deal is consummated, Pfizer will make a $5 million equity investment at a 25 percent premium to INHL’s current market price. The pharma company will make a second $5 million equity investment at the same premium upon the achievement of an undisclosed milestone. INHL has 8.7 million shares outstanding prior to the investment.

Pfizer will receive worldwide rights in exchange for funding further R&D efforts and providing INHL an undisclosed up front payment, milestone payments and royalties on sales. ...